Introduction

Venous thrombosis is a clinically relevant diagnosis, which can occur throughout the whole venous system [1]. In particular, oncology patients have an elevated risk for thrombosis with potentially life-threating complications, such as pulmonary embolism [2]. Hence, reliable diagnosis is mandatory for appropriate treatment to reduce morbidity and mortality [3]. However, venous thrombosis is often an incidental finding in patients who underwent computed tomography (CT) examinations not focused on the venous system, such as oncological follow-up examinations in portal-venous phase (CTPV) [4, 5]. Thus, it may remain challenging to accurately differentiate between venous thrombosis and iodine contrast media flux artefacts (IFA), which is caused by inflow of non-contrast enhanced blood [6]. This topic is of clinical relevance because ultrasound is the modality of choice for the diagnosis VT and is often limited by artefacts caused by the patient’s constitution and the examined area, e.g. the abdomen and pelvis due to air-filled bowl loops [7, 8].

In this context, recent developments in dual-energy CT (DECT) post-processing may serve as potential solution for a reliable detection of venous thrombosis by calculating iodine maps (IM) and noise-optimised monoenergetic extrapolations (MEI+) [6, 9]. IM allow for iodine quantification [10] and MEI+ at low keV levels promotes iodine-based attenuation with increased contrast-to-noise and signal-to-noise ratios [9]. Some studies have been published indicating the benefit of IM and MEI+ to improve image quality and diagnostic accuracy for pathologies of the portal-venous and arterial vascular system [11,12,13,14,15,16]. However, limited research has been published evaluating the value of DECT post-processing for the venous system although this is of clinical significance [6, 17].

We hypothesised that calculating IM and MEI+ at 40 keV may help to improve diagnostic confidence and accuracy for evaluating the venous system in the setting of suboptimal and/or inhomogeneous venous contrast enhancement.

Therefore, the objective of this study was to investigate the accuracy of DECT-based iodine maps (IM) and monoenergetic extrapolations (MEI+) at 40 keV for the detection and differentiation of venous thrombosis (VT) from iodine flux artefacts (IFA) in comparison to CTPV.

Materials and methods

The local institutional review board approved this retrospective study of routine clinical data and waived the requirement for written informed consent.

Patient characteristics

From July 2015 to December 2016, the evaluation of the electronic patient reports revealed 122 consecutive oncological patients, who fulfilled the following inclusion criteria: (1) contrast-enhanced CT in the portal-venous phase and had incidental findings of either (2) suspected venous thrombosis or (3) contrast media flux artefacts mimicking a potential thrombosis and (4) of whom follow-up imaging [colour-coded ultrasound (n = 50) or venous-phase CT examination (n = 72) within 4 weeks] was available to confirm the diagnosis. To ensure a reliable diagnosis, venous-phase CT was performed for suspected thrombosis in the thoracic and abdominopelvic vasculature. If thrombosis was suspected in the cervical or femoral veins, ultrasound was used. 23 patients were excluded due to severe artefacts caused by metallic implants resulting in non-diagnostic image quality of the adjacent vasculature. Thus, 99 patients (n = 68 with thrombosis in follow-up; n = 31 no thrombosis in follow-up) were included as final study cohort with follow-up imaging serving as the reference standard.

Acquisition parameters and Image reconstruction

All examinations were performed on a third-generation dual-source CT system (Somatom Force; Siemens Healthineers, Erlangen, Germany) in DE mode. Images were acquired in the portal-venous phase 90 s after body-weight adapted contrast agent administration (0.5 gl/kg, Imeron 400; Bracco, Milan, Italy) at a flow rate of 2.0 ± 0.5 ml/s using a dual-syringe power injector (Medrad; Bayer, Leverkusen, Germany) followed by a saline flush (40 ml). All examinations were performed with automatic attenuation-based tube current modulation (CareDose4D). Acquisition parameters were: tube A 90 kV and tube B Sn150 kV with reference tube-current time product of 190 mAs and 95 mAs, respectively. Collimation was 0.6 × 192 mm, pitch 0.6, and gantry rotation time 0.5 s.

Axial images were reconstructed using an advanced modelled iterative reconstruction algorithm (ADMIRE, strength level 2; Siemens Healthineers) with a medium soft kernel (Qr40d) and a slice thickness and increment of 3 mm. For linear blended images, a mixing ratio of 0.8 (tube A:B) was used to calculate 120 kV equivalent mixed images. IM and noise-optimised MEI+ at 40 keV were reconstructed using commercially available software (syngo.via VB10B; Siemens Healthineers) for DECT post-processing.

Image analysis

All image analyses were performed on a workstation using dedicated DE post-processing software (syngo.via, VB10B; Siemens Healthineers)

Reference standard

The reference standard was established by a radiologist with 7 years (C.S.) of training in vascular and abdominal imaging and based on colour-coded ultrasound or follow-up CT imaging.

Diagnostic confidence

Two readers with 4 (J.W.) and 7 (M.B.) years of experience in CT imaging assessed all reconstructions for the presence/ absence of venous thrombosis or iodine flux artefacts independently. If more than one thrombosis was diagnosed (n = 3), only the dominant site was included in the final analysis. In addition, the diagnostic confidence was rated on a three-point Likert scale (3 = high confidence; 2 = moderate confidence; 1 = low confidence). To ensure unbiased reading results, the reading was performed in a random order and both readers were blinded to clinical diagnosis and the localisation of the thrombosis. In addition, the individual reconstructions (CTPV, IM, MEI+) of a single patient were reviewed in different reading sessions with a time interval of at least 6 weeks to reduce recall bias.

Thrombus volume

To evaluate whether the mode of reconstruction affects the detectable thrombus size, the actual volume was estimated by measuring the size in all three spatial dimensions (formula 1). The reliability of the measurement was rated on a three-point Likert scale (3 = excellent reliability; 2 = moderate reliability; 1 = poor reliability).

$$ \mathrm{Thrombus}\ \mathrm{volume}\ \left[{\mathrm{ml}}^3\right]=\frac{\mathrm{length}\ \left[\mathrm{cm}\right]\times \mathrm{width}\ \left[\mathrm{cm}\right]\times \mathrm{height}\ \left[\mathrm{cm}\right]}{2} $$
(1)

Contrast-to-noise ratio (CNR) and iodine quantification

To obtain quantitative image parameters and calculate the CNR and iodine density, attenuation [Hounsfield units (HU)] / iodine content in the VT and IFA was measured on CTPV, IM and MEI+ by the same two radiologists in consensus. To reduce measurement errors, three individual regions of interest of 1-3 cm2 (ROIthrombus/artefact1-3) were placed within VT or IFA, on three adjacent slices without involving the thrombus/artefact border. Additionally, three ROIs (ROIvessel1-3) were placed in the contrast-enhanced vessel adjacent to VT/IFA on the same slices. ROI size and location were kept identical for all reconstructions of a patient. Subsequently, CNR was calculated for the different reconstructions of VT and IFA using the following equation:

$$ CNR=\frac{\left({HU}_{vessel}-{HU}_{thrombus/ artefact}\right)}{\left(\frac{SD_{vessel}+{SD}_{thrombus/ artefact}}{2}\right)} $$
(2)

Statistical analysis

All statistical analyses were performed using SPSS Statistics (version 22; IMB SPSS, Armonk, NY, USA). As Shapiro-Wilk test revealed non-normally distributed data, thrombus volume and CNR of VT/ IFA were compared using Wilcoxon signed-rank test for multiple comparisons. Results are given as median with interquartile range in parentheses.

Diagnostic accuracy was evaluated by calculating receiver operating characteristic (ROC) curves of the CNR analysis with area under the curves (AUCs) as well as the corresponding 95% confidence intervals (CIs) for CTPV images, IM and MEI+ 40 keV reconstructions.

Subjective measurement reliability of thrombus volume was compared using Wilcoxon signed-rank test.

For inter-reader agreement, Cohen’s kappa was calculated and interpreted as follows: κ < 0.2 poor; κ = 0.2 – 0.4 fair; κ = 0.4 – 0.6 moderate; κ = 0.6 – 0.8 substantial; κ > 0.8 perfect. A p value of less than 0.05 was considered statistically significant.

Results

DECT-based post-processing and image analysis was performed successfully in all patients. Patient characteristics and radiation doses are provided in Table 1.

Table 1 Patient demographics and dose values for the whole-body CT of the 99 subjects included in the analysis

Diagnostic confidence

Diagnostic confidence for differentiation of thrombosis from iodine flux artefacts was rated moderate (median 2; range 1 - 3) in CTPV images by both readers. In IM and MEI+ reconstructions, reading scores increased for both readers and both modes of reconstruction indicating a significantly higher diagnostic confidence in comparison to the CTPV images (both medians, 3; range, 2-3; p = 0.03 and p = 0.02, respectively), whereas no significant differences were found between IM and MEI+ (p = 0.7). An image example is provided in Fig. 1. Inter-reader agreement was substantial ranging from 0.6-0.7.

Fig. 1
figure 1

Ultrasound (a) and curved multiplanar reconstructions focused on the on left common iliac and right femoral vein. CTpv images (b) revealed thrombosis of the left common iliac vein and inhomogeneous attenuation, but no clear thrombus in the right femoral vein. Iodine maps (c) as well as monoenergetic reconstructions at 40 keV (d) clearly show an additional thrombosis of the right femoral vein, which could be confirmed with (colour-coded) ultrasound serving as standard of reference

Thrombus volume

The reliability for the measurement of the thrombus volume was rated moderate in CTPV (median, 2; range, 1-3) and excellent in IM and MEI+ 40 keV reconstructions with significantly higher values in comparison to CTPV (IM median, 3; range, 5-5; p = 0.01; MEI+ 40 median, 3; range, 4-5; p = 0.03) and with a substantial inter-reader agreement of 0.7.

Measured thrombus volume was 2.5 ± 5.7 ml3 for CTPV, 2.9 ± 6.4 ml3 for IM and 3.5 ± 8.0 ml3 for MEI+ with significantly higher values for MEI+ compared to IM and CTPV (p < 0.001) while a trend towards higher thrombus volume was found between CTPV and IM (p = 0.06).

Iodine quantification

Iodine quantification revealed significantly lower amounts of iodine in venous thrombosis [0.55 mg/ml (0.23-0.90)] than in the iodine flux artefacts [1.81 (1.60-2.12) mg/ml; p < 0.001).

CNR and ROC analyses

CNR was significantly higher in IM (median, 11.5; range, 8.5-14.5, p < 0.001) and MEI+ reconstructions (median, 10.9; range, 8.8-15.5, p < 0.001) compared to the CTPV images (median, 8.2; range, 5.8-11.4; see Fig. 2). No significant differences were found in the iodine flux artefacts among IM (median, 5.8; range, 4.6-7.6; p = 0.2), MEI+ (median, 5.5; range, 4.4-7.1) and CTPV (media 5.3; range, 3.7-6.7; p = 0.3).

Fig. 2
figure 2

Box-plots of contrast-to-noise ratio (CNR) values from portal-venous phase CT (PV), monoenergetic extrapolations (MEI+) and iodine mapping (IM) from DECT. CNR of thrombosis increased significantly using IM and MEI+ reconstruction. Boxes indicate ranges, lines within boxes indicate medians and vertical lines and whiskers denote 95% CIs

ROC analyses of CNR for the differentiation of venous thrombosis and iodine flux artefacts revealed highest values for IM [AUC, 0.88 (0.79-0.94); Youden Index, 0.67] followed by MEI+ [AUC, 0.86 (0.77-0.92); Youden Index, 0.64] and CTPV [AUC, 0.75 (0.65-0.84); Youden Index, 0.53, see Fig. 3). Pairwise comparison of ROC curves showed significantly larger areas under the curve for IM [Difference, 0.12 (0.06-0.19), p < 0.01] and MEI+ [Difference, 0.10 (0.02-0.19), p = 0.01] in comparison with CTpv, whereas no significant differences were found between IM and MEI+ [Difference, 0.02 (-0.04 to 0.07), p = 0.52].

Fig. 3
figure 3

ROC analysis of CNR from portal-venous phase CT (PV), monoenergetic extrapolation (MEI+) and iodine mapping (IM) from DECT for differentiating between venous thrombosis and iodine flux artefact. The area under the curve was larger for MEI+ and IM than for PV. Circles indicate points with highest Youden indices

Sensitivity and specificity was [79.1% (67.4-88.1); 87% (66.4-97.2)] for IM, [73.1% (60.9-83.2); 91.3% (72-98.9)] for MEI+ and [61.2% (48.5-72.9); 91.3% (72.0-98.9)] for CTPV.

Discussion

In this study, we investigated the diagnostic value of DECT-based iodine quantification and noise-optimised monoenergetic extrapolations for the detection of venous thrombosis and differentiation from iodine flux artefacts. Our results indicate that DECT post-processing with IM and low-keV MEI+ allows for significantly improved diagnostic confidence and diagnostic accuracy for the detection and differentiation of venous thrombosis from iodine flux artefacts in comparison to CTPV.

These results are of clinical interest, as venous thromboses are often diagnosed as incidental findings, especially in oncological follow-up examinations acquired in portal-venous phase. An inhomogeneous venous enhancement, in particular in the pelvic veins, impedes a reliable differentiation of potential thromboses from iodine flux artefacts. Moreover, the ongoing organisation of the thromboses over time is responsible for rendering therapeutic interventions ineffective, such as thrombolysis, thus requiring an accurate and early diagnosis, ideally within the first 20 days [18, 19]. Furthermore, the CT density of a thrombosis seems to vary [20] and has shown to increase over time [21] with the potential to gain identical attenuation as the surrounding blood, making a reliable diagnosis even more difficult. In these cases, as exemplary shown in Fig. 2, the improved image contrast of IM and MEI+ seems to have the highest value to support an accurate differentiation between thrombosis and iodine flux artefacts with significantly higher accuracy than CTPV images.

Although in many cases no DE post-processing is necessary to establish a final diagnosis, it seems helpful to increase diagnostic confidence in comparison to CTPV images alone, as our analysis revealed significantly higher subjective reading and diagnostic confidence scores for both readers with IM and MEI+ than with the CTPV reconstructions. This may reduce the number of additionally required examinations like ultrasound or CT venography. Although colour-coded ultrasound is a quick and non-invasive method to verify questionable findings in CT examinations of the cervical and lower extremity veins, the diagnostic performance in the thorax as well as in the abdominopelvic region can be limited, e.g. due to gas overlay or obesity [7, 8, 22]. In these cases, CT venography has evolved as a viable diagnostic tool with high sensitivity and specificity due to high iodine load in the venous system, which guarantees a more homogenous enhancement and consecutively improved contrast of the iodinated blood to the suspected thrombus [23, 24]. However, this procedure requires a second CT examination with additional radiation exposure and intravenous contrast administration [25, 26]. One possibility to compensate for these drawbacks is the use of examination protocols at reduced kVp settings [23, 24]. Due to the closer proximity of the mean photon energy to the iodine k-edge at 33.2 keV, the vascular attenuation can be significantly increased [27, 28]. However, this must be decided in advance and may be at the expense of the image quality of the parenchymal organs. In contrast, the calculation of MEI+ at low keV values provides the same effect and CTPV mixed images allow for optimal assessment of the abdominopelvic organs. Furthermore, the calculation of IM provides additional information on the quantitative iodine distribution and helps to evaluate questionable results, as previously reported in an ex vivo study [6].

As shown in our quantitative analysis, CNR calculations can support the visual diagnosis to differentiate between venous thrombosis and iodine flux artefacts with highest diagnostic accuracy for iodine maps followed by MEI+. This may be especially helpful if the vessel enhancement is poor or inhomogeneous or if the visual appearance of the finding is questionable due to ill-defined borders or atypical morphology. In these cases, quantitative iodine density measurement may be more accurate than the visual assessment and can serve as an objective decision-making tool.

This study has the following limitations. First, the follow-up interval of 4 weeks is relatively long. However, a new occurrence of a thrombosis at exactly the same location seems rather unlikely. Second, we did not subdivide the thrombosis into non-neoplastic and neoplastic thrombi because the sample size of suspected neoplastic thrombi in our study cohort was too small for a reliable statistical analysis, although neoplastic thrombi may show an increased iodine uptake [11, 12]. In addition, measurement of thrombus volume was only performed in the three evaluated reconstructions (CTPV, MEI+ and IM) and lacks the comparison with the reference standard (venous-phase CT or colour-coded ultrasound), since in most cases no adequate (3D) images of the ultrasound examinations were available in the PACS archive to reliably estimate the thrombus volume. Finally, the retrospective study design is prone to selection bias, which needs to be considered for data interpretation and no information was available, to verify whether or how often DE post-processing was performed in the initial clinical reading.

In conclusion, our results indicate that DE post-processing with IM and MEI+ allows for significantly improved diagnostic confidence and diagnostic accuracy for the detection and differentiation of venous thrombosis from iodine flux artefacts in comparison to CTPV with highest diagnostic confidence and accuracy in the IM reconstructions. This seems particularly useful to rule out a suspected iodine flux artefact rather than to confirm a real venous thrombosis.